stockrowArdelyx, Inc. (ARDX) vs Lexicon Pharmaceuticals, Inc. (LXRX)
- Ardelyx, Inc. ARDX 2.86 −4.35%
- Lexicon Pharmaceuticals, Inc. LXRX 1.79 +11.18%
Ardelyx, Inc. and Lexicon Pharmaceuticals, Inc. are both Biotechnology companies. Ardelyx, Inc. and Lexicon Pharmaceuticals, Inc. are of similar size ($751.6M and $716.4M). Ardelyx, Inc. grew revenue faster over the last twelve months: 17.6% against −45.6%. Ardelyx, Inc. has the higher net margin (−11.9% vs −161.8%) and the higher return on invested capital (−17.2% vs −109.1%). Across the 18 metrics below, Ardelyx, Inc. leads on 13 and Lexicon Pharmaceuticals, Inc. on 5.
Valuation
Profitability
| Metric | ARDX | LXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 94.46% | 98.89% | 68.51% |
| Operating margin | (7.71%) | (147.42%) | 0.00% |
| Net margin | (11.85%) | (161.80%) | 0.00% |
| Free cash flow margin | (3.41%) | (127.76%) | 0.00% |
| Return on equity | (34.85%) | (43.91%) | (51.96%) |
| Return on assets | (10.33%) | (27.84%) | (46.06%) |
| Return on invested capital | (17.21%) | (109.13%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack